- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03311802
A Risk Scores for Predicting Prevalence of Diabetes in the LAO Population
This was a cross-sectional investigation conducted from December 2015 to July 2017, in 15 selected rural villages of 2 districts of Vientiane municipality, Lao PDR. Target population was interested people, both men and women of age range between 30 to 70 years, living in the selected community. Someone diagnosed with diabetes and/or using any anti-diabetic drug was excluded.
The study protocol initiated with the interview on demographic and behavior information with each participant, followed by physical exam and blood pressure measurement.
Fasting glucose were measured.
Study Overview
Status
Conditions
Detailed Description
All participants were invited to meet with the researcher.
Demographic data comprises of age, gender, family history of diabetes including parents and sibling, female with history of having baby weighing more than 4 kg, gestational diabetes, and history or current of dyslipidemia (triglycerides >150 mg/dl, LDL-C ≥ 100 mg/dl, HDL-c < 35 mg/dl), and behavior data were smoking habit, physical inactivity (less than 150 min/week or 3 day/week) were collected by interview.
After that each participant was appointed for blood pressure measurement. Body mass index was computed from body weight (kg) divided by body height (m2) using the weight and height scale.
Waist Circumference was measured at the midpoint between the superior border of iliac crest and the lowest rib using measuring tape with the subject in the position of standing relax and in underclothes
Hip circumference is measured at the level of maximal gluteal protrusion
Blood pressure (BP) value was done with the participants, after 5 minutes relaxing, sitting up right with their upper arm positioned at heart level and measured by Omron blood pressure monitor.
Fasting Plasma Glucose was utilized to identify an individual who is normal, has either pre-diabetes or undiagnosed diabetes. Venous blood samples were collected 5 ml from antecubital vein into the test tube
Study Type
Enrollment (Actual)
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- of age range between 30 to 70 years, living in the selected community.
Exclusion Criteria:
- diagnosed with diabetes and/or using any anti-diabetic drug
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
1
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
fasting plasma glucose
Time Frame: 06.00-09.00 am
|
overnight fasting blood glucose
|
06.00-09.00 am
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- risk scores predicting DM
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Undiagnosed Diabetes
-
Glyconics LtdRecruiting
-
University of PittsburghHorizon Pharma USA, Inc.RecruitingUndiagnosed DiseaseUnited States
-
Wayne State UniversityTerminated
-
National Human Genome Research Institute (NHGRI)University of VirginiaCompletedUndiagnosed DiseaseUnited States
-
National Human Genome Research Institute (NHGRI)CompletedUndiagnosed DiseaseUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)RecruitingCardiovascular Disease | Undiagnosed DiseasesUnited States
-
Mayo ClinicEnrolling by invitationRare Diseases | Undiagnosed DiseaseUnited States
-
National Human Genome Research Institute (NHGRI)RecruitingGenetic DiseaseUnited States
-
The University of Hong KongHealth Care and Promotion Fund, Government of the Hong Kong SARCompletedUndiagnosed Psychological ProblemsHong Kong
-
Mayo ClinicEnrolling by invitationUndiagnosed Diseases | Rare Genetic DiseaseUnited States